Prostate‐specific antigen obtained under optimal conditions determines extracapsular adenocarcinoma of the prostate
- 1 January 1995
- journal article
- Published by Wiley in British Journal of Urology
- Vol. 75 (1) , 21-25
- https://doi.org/10.1111/j.1464-410x.1995.tb07226.x
Abstract
To assess the relationship of prostate-specific antigen (PSA) obtained under optimal conditions with the presence or absence of organ-confined prostate cancer following radical prostatectomy. The medical records of 300 consecutive patients who underwent radical retropubic prostatectomy were retrospectively reviewed. Ninety-three patients were excluded who had a pre-operative PSA level potentially altered by various factors (prostate infection, manipulation or instrumentation). A pre-operative PSA value < 4 ng/mL accurately predicted pathologically confined disease in 42 of 51 patients (82%) which contrasted with extracapsular disease in 74 of 84 patients (88%) who had a PSA value > 10 ng/mL. One of the 53 patients with a PSA > 15 ng/mL had organ-confined disease at surgery. These data demonstrate that optimal serum PSA values correlate well with pathological stage.Keywords
This publication has 19 references indexed in Scilit:
- The TNM classification of prostate cancerThe Prostate, 1992
- Preoperative prostate-specific antigen in predicting pathologic stage and grade after radical prostatectomyUrology, 1991
- Prostate Specific Antigen in the Staging of Localized Prostate Cancer: Influence of Tumor Differentiation, Tumor Volume and Benign HyperplasiaJournal of Urology, 1990
- Determination of prostate-specific antigen in serum by immunoradiometric assayClinical Chemistry, 1990
- The Value of Serum Prostate Specific Antigen Determinations Before and after Radical ProstatectomyJournal of Urology, 1989
- The Value of the Measurement of Serum Prostate Specific Antigen in Patients with Benign Prostatic Hyperplasia and Untreated Prostate CancerBritish Journal of Urology, 1988
- Prostate Specific Antigen in the Preoperative and Postoperative Evaluation of Localized Prostatic Cancer Treated with Radical ProstatectomyJournal of Urology, 1988
- Prostatic Specific Antigen and Prostatic Acid Phosphatase in the Monitoring and Staging of Patients with Prostatic CancerJournal of Urology, 1987
- Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the ProstateNew England Journal of Medicine, 1987
- Correlation of Clinical Stage, Serum Prostatic Acid Phosphatase and Preoperative Gleason Grade with Final Pathological Stage in 275 Patients with Clinically Localized Adenocarcinoma of the ProstateJournal of Urology, 1987